These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28107247)

  • 1. Plaque burden, microstructures and compositions underachieving very low LDL-C levels.
    Kataoka Y; Andrews J; Puri R; Psaltis PJ; Nicholls SJ
    Curr Opin Endocrinol Diabetes Obes; 2017 Apr; 24(2):122-132. PubMed ID: 28107247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive lipid lowering therapy with titrated rosuvastatin yields greater atherosclerotic aortic plaque regression: Serial magnetic resonance imaging observations from RAPID study.
    Yogo M; Sasaki M; Ayaori M; Kihara T; Sato H; Takiguchi S; Uto-Kondo H; Yakushiji E; Nakaya K; Komatsu T; Momiyama Y; Nagata M; Mochio S; Iguchi Y; Ikewaki K
    Atherosclerosis; 2014 Jan; 232(1):31-9. PubMed ID: 24401214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plaque microstructures in patients with coronary artery disease who achieved very low low-density lipoprotein cholesterol levels.
    Kataoka Y; Hammadah M; Puri R; Duggal B; Uno K; Kapadia SR; Murat Tuzcu E; Nissen SE; Nicholls SJ
    Atherosclerosis; 2015 Oct; 242(2):490-5. PubMed ID: 26298740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Goal of Achieving Atherosclerotic Plaque Regression with Lipid-Lowering Therapy: Insights from IVUS Trials.
    Daida H; Dohi T; Fukushima Y; Ohmura H; Miyauchi K
    J Atheroscler Thromb; 2019 Jul; 26(7):592-600. PubMed ID: 31118346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial.
    Nicholls SJ; Puri R; Anderson T; Ballantyne CM; Cho L; Kastelein JJ; Koenig W; Somaratne R; Kassahun H; Yang J; Wasserman SM; Scott R; Ungi I; Podolec J; Ophuis AO; Cornel JH; Borgman M; Brennan DM; Nissen SE
    JAMA; 2016 Dec; 316(22):2373-2384. PubMed ID: 27846344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of statin intervention on mild coronary plaque progression assessed by serial coronary CT angiography].
    Li ZN; Hou ZH; Liu K; Wang ZQ; Yin WH; Gao Y; Xu HY; Jiang SL; Lyu B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Jun; 44(6):508-12. PubMed ID: 27346264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid profile associated with coronary plaque regression in patients with acute coronary syndrome: Subanalysis of PRECISE-IVUS trial.
    Tsujita K; Yamanaga K; Komura N; Sakamoto K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
    Atherosclerosis; 2016 Aug; 251():367-372. PubMed ID: 27318866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2017 Taiwan lipid guidelines for high risk patients.
    Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
    J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of PCSK9 inhibition on coronary atheroma progression: Rationale and design of Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound (GLAGOV).
    Puri R; Nissen SE; Somaratne R; Cho L; Kastelein JJ; Ballantyne CM; Koenig W; Anderson TJ; Yang J; Kassahun H; Wasserman SM; Scott R; Borgman M; Nicholls SJ
    Am Heart J; 2016 Jun; 176():83-92. PubMed ID: 27264224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The difference between Asian and Western in the effect of LDL-C lowering therapy on coronary atherosclerotic plaque: a meta-analysis report.
    Li YF; Feng QZ; Gao WQ; Zhang XJ; Huang Y; Chen YD
    BMC Cardiovasc Disord; 2015 Feb; 15():6. PubMed ID: 25971444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Intensive LDL Cholesterol Lowering on Coronary Artery Atherosclerosis Progression: A Serial CT Angiography Study.
    Shin S; Park HB; Chang HJ; Arsanjani R; Min JK; Kim YJ; Lee BK; Choi JH; Hong GR; Chung N
    JACC Cardiovasc Imaging; 2017 Apr; 10(4):437-446. PubMed ID: 27771404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins, LDL Cholesterol Control, Cardiovascular Disease Prevention, and Atherosclerosis Progression: A Clinical Perspective.
    Nesti L; Mengozzi A; Natali A
    Am J Cardiovasc Drugs; 2020 Oct; 20(5):405-412. PubMed ID: 31840213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin treatment and carotid plaque composition: a review of clinical studies.
    Puato M; Zambon A; Faggin E; Rattazzi M; Pauletto P
    Curr Vasc Pharmacol; 2014 May; 12(3):518-26. PubMed ID: 23092412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atheroma progression in hyporesponders to statin therapy.
    Kataoka Y; St John J; Wolski K; Uno K; Puri R; Tuzcu EM; Nissen SE; Nicholls SJ
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):990-5. PubMed ID: 25722430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plaque regression and improved clinical outcomes following statin treatment in atherosclerosis.
    Girotra S; Murarka S; Migrino RQ
    Panminerva Med; 2012 Jun; 54(2):71-81. PubMed ID: 22525562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
    Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
    Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study.
    Räber L; Taniwaki M; Zaugg S; Kelbæk H; Roffi M; Holmvang L; Noble S; Pedrazzini G; Moschovitis A; Lüscher TF; Matter CM; Serruys PW; Jüni P; Garcia-Garcia HM; Windecker S;
    Eur Heart J; 2015 Feb; 36(8):490-500. PubMed ID: 25182248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plaque REgression with Cholesterol absorption Inhibitor or Synthesis inhibitor Evaluated by IntraVascular UltraSound (PRECISE-IVUS Trial): Study protocol for a randomized controlled trial.
    Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Ono T; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
    J Cardiol; 2015 Oct; 66(4):353-8. PubMed ID: 25577723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.